Labor Market Pulse · Life Sciences · October 2026
Life Sciences Labor Market Report: Sioux City, IA-NE-SD MSA — October 2026
Sioux City pays a premium for scarce clinical and validation talent.
Metro Clinical Research Associate pay hit $121,250, above the $90,065 national median, while Validation Engineer pay reached $121,331 against a 3.7% Woodbury County unemployment rate signaling little slack to fill these roles.
Free archive edition. Published by WageScape as sent to subscribers; data as of October 2026.
Key indicators
- Woodbury County unemployment: 3.7% — Aug 2026, vs 4.1-4.2% national
- CRA advertised pay, metro vs national: $121,250 vs $90,065 — Metro exceeds national median
- National quit rate: 1.9% — Signals limited voluntary churn for backfill
- National lab/R&D vacancy rate: 23.2% — Top 13 US life sciences markets, Q1 2026
Key takeaways
Local CRA pay has overtaken the national median.
Metro Clinical Research Associate advertised pay sits at $121,250 versus a $90,065 national median — a reversal that suggests Sioux City employers are bidding aggressively for a role national data already flags as the clinical-ops bottleneck. Compensation benchmarking built on national CRA data will understate what it now takes to retain staff locally.
Validation engineering pay signals manufacturing retention stress.
Validation Engineer advertised pay rose to $121,331 locally, well above the $106,478 national median, consistent with CDMOs and device manufacturers competing for scarce bioprocess and quality-system expertise. Expect this premium to persist as long as nearly a quarter of the national life sciences workforce nears retirement age.
Clinical Data Manager pay is falling against a stable national trend.
Metro pay for this role dropped to $74,125 against a flat $123,653 national median, a gap wide enough to suggest thin local demand or a shift toward remote/outsourced data management as the cause, separate from any real wage softening. Worth testing before assuming the role is simply undervalued here.
Lab Technician pay decline adds friction to the talent pipeline.
Metro Lab Technician pay fell to $44,670 while the national figure held near $47,840, a divergence that may discourage entry-level scientific talent from staying in-market long enough to backfill departing mid-career staff. That pipeline gap compounds the retention risk already visible in higher-credential roles.
Median advertised pay by role — Sioux City, IA-NE-SD MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $74,306 | $107,497 | $113,084 | Significant increase | $130,339 |
| Clinical Research Associate * | $62,098 | $121,250 | $128,750 | Significant increase | $90,065 |
| Lab Technician * | $38,917 | $44,670 | $47,927 | Moderate decline | $47,840 |
| Regulatory Affairs Specialist * | $88,842 | $103,011 | $109,084 | Significant increase | $103,780 |
| Clinical Data Manager * | $74,125 | $74,125 | $99,228 | Significant decline | $123,653 |
| Biostatistician * | $91,938 | $124,129 | $146,223 | Stable | $131,958 |
| Validation Engineer * | $118,498 | $121,331 | $123,498 | Significant increase | $106,478 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Sioux City's labor market remains structurally tight, with Woodbury County unemployment at 3.7% in August 2026 against a national rate near 4.1-4.2%, leaving the metro with little slack to absorb new scientific or technical headcount without drawing talent from competitors. Iowa's statewide quit rate dynamics mirror the national 1.9% figure, meaning the metro's modest base of life sciences employers is competing for a largely stationary pool of experienced regulatory, quality, and clinical talent and cannot count on voluntary churn to ease the search.
What it means
Metro advertised pay for Clinical Research Associate ($121,250) and Validation Engineer ($121,331) now exceeds or rivals national medians, signaling that Sioux City employers are paying a premium to secure scarce credentialed talent in a market that offers no Midwest cost-of-living discount. That premium, paired with a 23.2% national lab/R&D vacancy rate and 1.9% quit rate, tightens the build-vs-outsource calculus for manufacturing and quality functions — local employers may struggle to fill specialized roles fast enough to avoid shifting volume to CDMO partners. Organizations should evaluate whether current CRA and validation engineering pay positions them to retain incumbents before testing the external market, given how thin local replacement supply appears to be.
Looking ahead
Early indicator: Watch whether October's national CRA and regulatory affairs vacancy data, due alongside Q4 biopharma hiring surveys, show continued tightening — any uptick would further justify the metro's above-national CRA pay.
Worth watching: Iowa's professional, scientific, and technical services sector lost jobs in September even as statewide unemployment held at 3.2%; a second consecutive month of losses would be a meaningful signal for R&D and regulatory headcount planning in the metro.
Potential inflection point: BLS has not yet released October metro-level unemployment data for Sioux City; its publication will clarify whether the 3.7% Woodbury County reading in August marked a plateau or the start of further tightening.
Emerging pressure point: National biopharma M&A activity is up 63% in H1 2026 alongside a 90% drop in layoffs — watch for regional ripple effects as consolidating organizations reassess manufacturing and quality footprints, which could reshape local build-vs-outsource decisions.
Sources
- Iowa Workforce Development — Woodbury County unemployment rate of 3.7% in August 2026
- Life sciences industry labor market research — National lab/R&D vacancy reached 23.2% in Q1 2026
- Bureau of Labor Statistics / industry survey — National quit rate of 1.9% limiting candidate availability
- Iowa Workforce Development — Iowa professional, scientific, technical services lost jobs in September 2026
- Biopharma industry labor market research — Biopharma M&A activity up 63% in H1 2026 with layoffs down 90% YoY
- Bureau of Labor Statistics — National unemployment rate 4.1%-4.2% range through 2026
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.